首页> 外文期刊>Molecular Carcinogenesis >Use of mononucleotide repeat markers for detection of microsatellite instability in mouse tumors.
【24h】

Use of mononucleotide repeat markers for detection of microsatellite instability in mouse tumors.

机译:使用单核苷酸重复标记物检测小鼠肿瘤中的微卫星不稳定性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Tumors lacking DNA mismatch repair activity (MMR) from patients with Hereditary Nonpolyposis Colorectal Cancer (HNPCC) or those with sporadic colorectal cancer can be identified by the presence of high levels of instability in repetitive sequences known as microsatellites (MSI). The assessment of MSI phenotype in human tumors helps to establish a clinical diagnosis and is accomplished with a reference panel of five mononucleotide repeats. By contrast, detection of MSI in mouse tumors has proven to be problematic and lack of a uniform set of markers for classification of MSI has impeded comparison of results between studies. We tested for MSI in intestinal tumors from MMR-deficient mice with four mononucleotide repeats with polyA(24-37) tracts and three new markers with extended polyA(59-67) tracts. All seven markers were sensitive to MSI in MMR-deficient tumors, but those with extended mononucleotide tracts displayed larger deletions, which were easily distinguishable from the germline alleles. With a panel of the five most sensitive and specific mononucleotide repeats, a high level of MSI was detected in 100% of MMR-deficient tumors, but not in tumors with MMR activity. This novel panel is an improvement over existing combinations of mono- and dinucleotide repeat markers and should facilitate MSI screening and standardize results from different studies.
机译:遗传性非息肉性结直肠癌(HNPCC)或散发性结直肠癌患者缺乏DNA错配修复活性(MMR)的肿瘤可以通过在称为微卫星(MSI)的重复序列中存在高度不稳定性来鉴定。对人类肿瘤中MSI表型的评估有助于建立临床诊断,并由五个单核苷酸重复序列的参考组来完成。相比之下,已证明在小鼠肿瘤中检测MSI是有问题的,并且缺乏用于MSI分类的统一标记集妨碍了研究之间的结果比较。我们在MMR缺陷小鼠的肠肿瘤中测试了MSI,该小鼠具有四个带有polyA(24-37)泳道的单核苷酸重复序列和三个带有扩展的polyA(59-67)泳道的新标记。在缺乏MMR的肿瘤中,所有七个标记物均对MSI敏感,但是具有延伸的单核苷酸束的标记物则显示出较大的缺失,这很容易与种系等位基因区分开。使用五个最敏感和最特异性的单核苷酸重复序列,在100%MMR缺陷型肿瘤中检出了高水平的MSI,而在具有MMR活性的肿瘤中未检出。这个新颖的小组是对现有的单核苷酸重复标记和二核苷酸重复标记的组合的一种改进,应有助于MSI筛选并标准化来自不同研究的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号